{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:52:23Z","timestamp":1792079543420,"version":"4.4.0"},"reference-count":11,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,15]]},"DOI":"10.1182\/blood.2026033711","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:31:52Z","timestamp":1792078312000},"page":"1950-1952","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["T cells targeting immunoglobulin in myeloma: a way forward?"],"prefix":"10.1182","volume":"148","author":[{"given":"David E.","family":"Avigan","sequence":"first","affiliation":[{"name":"Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"16","key":"2026101511314971200_bib1","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood.2025031897","article-title":"TCR T cells targeting IgA- and IgG-expressing multiple myeloma","volume":"148","author":"Douvlataniotis","year":"2026","journal-title":"Blood"},{"issue":"16","key":"2026101511314971200_bib2","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/blood.2025032234","article-title":"Immunoglobulin constant domains as targets for T-cell receptor\u2013based treatment of multiple myeloma","volume":"148","author":"Meeuwsen","year":"2026","journal-title":"Blood"},{"issue":"8","key":"2026101511314971200_bib3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa2024850","article-title":"Idecabtagene vicleucel in relapsed and refractory multiple myeloma","volume":"384","author":"Munshi","year":"2021","journal-title":"N Engl J Med"},{"issue":"25","key":"2026101511314971200_bib4","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1200\/JCO-25-00760","article-title":"Long-term (\u22655-year) remission and survival after treatment with ciltacabtagene autoleucel in CARTITUDE-1 patients with relapsed\/refractory multiple myeloma","volume":"43","author":"Jagannath","year":"2025","journal-title":"J Clin Oncol"},{"issue":"697","key":"2026101511314971200_bib5","doi-asserted-by":"crossref","first-page":"eabe2606","DOI":"10.1126\/scisignal.abe2606","article-title":"Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function","volume":"14","author":"Salter","year":"2021","journal-title":"Sci Signal"},{"issue":"1","key":"2026101511314971200_bib6","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1038\/s41467-025-59904-x","article-title":"Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire","volume":"16","author":"Cheloni","year":"2025","journal-title":"Nat Commun"},{"issue":"7","key":"2026101511314971200_bib7","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41591-019-0472-9","article-title":"T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant","volume":"25","author":"Chapuis","year":"2019","journal-title":"Nat Med"},{"issue":"8","key":"2026101511314971200_bib8","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm.3910","article-title":"NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma","volume":"21","author":"Rapoport","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"2026101511314971200_bib9","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1038\/s41467-023-38946-z","article-title":"Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors","volume":"14","author":"Schmidt","year":"2023","journal-title":"Nat Commun"},{"issue":"17","key":"2026101511314971200_bib10","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1182\/blood.2023021979","article-title":"Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia","volume":"143","author":"Leung","year":"2024","journal-title":"Blood"},{"issue":"9","key":"2026101511314971200_bib11","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41591-024-03109-0","article-title":"Adoptive transfer of personalized neoantigen-reactive TCRtransduced T cells in metastatic colorectal cancer: phase 2 trial interim results","volume":"30","author":"Parkhurst","year":"2024","journal-title":"Nat Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/16\/1950\/2594887\/blood_bld-2026-033711-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/16\/1950\/2594887\/blood_bld-2026-033711-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:31:53Z","timestamp":1792078313000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/16\/1950\/571436\/T-cells-targeting-immunoglobulin-in-myeloma-a-way"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":11,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026,10,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2026033711","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,15]]},"published":{"date-parts":[[2026,10,15]]}}}